Company intelligence / Profile preview

FunPep

Tokyo, Tokyo Prefecture, Japanfunpep.co.jp ↗
Ownership
Private
Development stage
Phase 3
01

Overview

FunPep has developed a proprietary platform for creating functional and antibody-inducing peptides. Its lead program, FPP003, completed a PI/IIa trial showing it was generally well tolerated with no serious adverse events and demonstrated immunological response in humans. The company claims to be the first to produce sustained antibodies via administration of a peptide alone, confirming the concept of antibody-inducing peptides in clinical trials[5].

Therapeutic areas
OncologyImmunologyCardiovascularNeurologyInfectious Diseases
Modalities
PeptidesAntibody-inducing peptidesFunctional peptidesPeptide-based medicines[1][3][5]
Industry
Biotech
02

Drug pipeline

5 assets

FPP003

2

4 more assets in the full pipeline.

03

Partnerships

Shionogi & Co., Ltd. – Lead asset licensed for allergy vaccine development [1][3]Sumitomo Pharma – Optioned clinical asset [3]MEDIPAL HOLDINGS CORPORATION – Exercised option agreement [1]

Beyond the preview

Go deeper on FunPep.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FunPep.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call